Antibody testing for cardiac antibody-mediated rejection: Which panel correlates best with cardiovascular death?

The combination of complement components, HLA-DR and fibrin, is valuable in defining AMR in patients at risk for allograft loss from cardiovascular causes. Fibrin is particularly important for detecting the presence of severe AMR, with a high likelihood of poor long-term patient outcome.